STAT3 and breast carcinoma: In breast cancer, CD155 can enhance mitochondrial fatty acid β-oxidation via the CD155-CD96-Src-Stat3-Opa1 signaling axis, thereby promoting the chemotherapy resistance of breast cancer stem cells [14].